logo-loader
RNS
Assura Group

Assura plc - Replacement Scrip Dividend Declaration

RNS Number : 5948J
Assura PLC
14 April 2020
 

14 April 2020

Assura plc

Replacement Scrip Dividend Declaration

This announcement replaces the previous announcement made by the Company under RNS Number 2740J at 7.00 a.m. on 9 April 2020. This replacement announcement includes a revised Admission date of 15 April 2020 for the New Shares. All other details remain the same.

 

Assura plc ("Assura" or "the Company"), the UK's leading primary care property investor and developer, today announces that, pursuant to its Scrip Dividend Scheme and in response to the scrip dividend alternative for the quarterly interim dividend payable on 15 April 2020 (the "Scrip Dividend Alternative"), elections were received in respect of 29 per cent. of the Company's ordinary shares in issue as at the record date of 13 March 2020.

Electing shareholders will receive ordinary shares in the Company ("Shares") in lieu of cash in respect of this dividend and, accordingly 6,543,440 Shares (the "New Shares") will be issued by the Company to such shareholders.

Application has therefore been made for the admission of the New Shares to the Official List of the UK Listing Authority and to trading on the London Stock Exchange's market for listed securities ("Admission"). The New Shares will rank pari passu with the Company's existing ordinary shares and Admission is expected to occur at 8.00am on 15 April 2020.

Following the allotment of the New Shares, it is expected that the total number of shares in issue will be 2,659,993,187 (none of which will be held in treasury) and that, accordingly, the total number of voting rights of the Company will be 2,659,993,187.

Copies of the documents relating to the Scrip Dividend Alternative are available for inspection through the National Storage Mechanism (http://www.morningstar.co.uk/uk/NSM).

This interim dividend is 100% Property Income Distribution ("PID").

Forms to register for gross PIDs (on future interim dividends) are available on the Company's website. Please click here for PID Forms.

-ENDS-

For more information, please contact:

 

Assura plc

 

Tel: 01925 420660

Orla Ball, Company Secretary

David Purcell, Head of Financial Reporting

 



Finsbury

Gordon Simpson
James Thompson

Tel: 0207 251 3801

 

Notes to Editors

Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create outstanding spaces for health services in our communities. At 30 September 2019, Assura's property portfolio was valued at £2,039 million.

Further information is available at www.assuraplc.com

*EPRA is a registered trademark of the European Public Real Estate Association
Assura plc LEI code: 21380026T19N2Y52XF72


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DIVGPUUWCUPUGGC
NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of...

FOR OUR FULL DISCLAIMER CLICK HERE

3 min read